ストックスクリーナーアプリを入手
1.40
5.41%
-0.08
アフターアワーズ：
1.40
前日終値:
$1.48
開ける：
$1.47
24時間の取引高:
3.13M
Relative Volume:
0.50
時価総額：
$434.84M
収益：
$160.03M
当期純損益:
$-128.58M
株価収益率:
-3.2802
EPS:
-0.4268
ネットキャッシュフロー:
$-121.21M
1週間 パフォーマンス:
+2.94%
1か月 パフォーマンス:
-16.67%
6か月 パフォーマンス:
-38.05%
1年 パフォーマンス:
+1.45%
1日の値動き範囲:
$1.39
$1.48
1週間の範囲:
$1.32
$1.49
52週間の値動き範囲:
$1.09
$2.73
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
名前
Pacific Biosciences Of California Inc
セクター
電話
650-521-8000
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
Compare PACB vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
1.40 | 422.42M | 160.03M | -128.58M | -121.21M | -0.4268 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-06 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2024-11-11 | ダウングレード | UBS | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-04-18 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-17 | アップグレード | UBS | Neutral → Buy |
| 2023-10-31 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-06-30 | 開始されました | Goldman | Buy |
| 2023-05-10 | 開始されました | Barclays | Equal Weight |
| 2023-03-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2023-01-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Neutral |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 開始されました | Cowen | Outperform |
| 2017-11-03 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | ダウングレード | CL King | Buy → Neutral |
| 2016-11-03 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2016-06-27 | 開始されました | CL King | Buy |
| 2016-04-15 | 開始されました | First Analysis Sec | Overweight |
| 2016-02-04 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-10-23 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-02-04 | 繰り返されました | Maxim Group | Buy |
| 2013-09-26 | 繰り返されました | Maxim Group | Buy |
| 2013-01-14 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Pacific Biosciences Of California Inc (PACB) 最新ニュース
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pacific Biosciences of California, Inc. Revenue Breakdown – NASDAQ:PACB - TradingView
PACB|Pacific Biosciences of California Inc|Price:1.360|Chg%:-0.040 - TradingKey
Pacific Biosciences of California Inc (PACB) Institutional Confidence - TradingKey
Pacific Biosciences of California Inc - TradingKey
Pacific Biosciences of California Inc (PACB) Cash Flow - TradingKey
PACB|Pacific Biosciences of California Inc|Price:1.360| - TradingKey
Pacific Biosciences of California Inc (PACB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pacific Biosciences of California Inc (PACB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pacific Biosciences of California Inc (PACB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PACB stock reflects Illumina merger plan as investors weigh 2025 revenue outlook - Ad-hoc-news.de
Pacific Biosciences of California offers expert guidance for targeted sequencing applications - Traders Union
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market - Yahoo Finance
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 - Moomoo
PacBio’s next earnings update will stream live Aug. 5 - Stock Titan
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Pacific Biosciences of California launches Rapid HiFi WGS Resource Bundle to accelerate genomic research - Traders Union
Pacific Biosciences (PACB) Proxy filing Summary - Quartr
Pacific Biosciences of California launches multi-use SMRT Cell for affordable high-quality WGS - Traders Union
Pacific Biosciences of California (PACB) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Pacific Biosciences Announces Resignation of Board Member - TipRanks
Pacific director Christopher M. Smith resigns from board - TradingView
[8-K] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Reports Material Event - Stock Titan
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth - TradingView
Pacific Biosciences of California opens registration for webinar on SPRQ-Nx chemistry driving efficiency gains - Traders Union
Here's why you should add PacBio stock to your portfolio now - MSN
Pacific Biosciences (PACB) Stephens Annual Investment Conference Summary - Quartr
Here's Why You Should Add PacBio Stock to Your Portfolio Now - Yahoo Finance
Pacific Biosciences updates its sequencing strategy. Investors watch long-read technology - ad-hoc-news.de
Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Is Pacific Biosciences (PACB) The Best Rising Penny Stock? - Insider Monkey
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Attendance surges at Pacific Biosciences of California charity run, boosting genetic testing support - Traders Union
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2500 Growth Benchmark - marketscreener.com
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2000 Growth Benchmark - marketscreener.com
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000E Growth Benchmark - marketscreener.com
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000 Growth Benchmark - marketscreener.com
PacBio (PACB) Stock Faces Mixed Analyst Target Changes After Valuation Revisions - Yahoo Finance
Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. – NASDAQ:PACB - TradingView
Pacific Biosciences of California, Inc. Actuals & Estimates (NASDAQ:PACB) - TradingView
PACIFIC BIOSCIENCES OF CALIFORNIA ROE % Adjusted to Book Val - GuruFocus
Enterprise value to revenue forward of Pacific Biosciences of California, Inc. – FWB:P09 - TradingView
Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. – FWB:P09 - TradingView
PACB Forecast — Price Target — Prediction for 2027 - TradingView
PACB Stock Gains Focus As New Sequencing Tech Slashes Genome Costs - StocksToTrade
Price to book forward of Pacific Biosciences of California, Inc. – NASDAQ:PACB - TradingView
Pacific Biosciences of California launches kit to streamline high-throughput sequencing operations - Traders Union
Price to sales forward of Pacific Biosciences of California, Inc. – NASDAQ:PACB - TradingView
Pacific Biosciences Of California Inc (PACB) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):